Spain's Proposed E-cigarette and Nicotine Pouch Restrictions Spark EU Debate

Aug.21.2025
Spain's Proposed E-cigarette and Nicotine Pouch Restrictions Spark EU Debate
Lead: Spain's proposed e-cigarette and nicotine pouch restrictions face strong opposition from seven EU countries and the European Commission.

Key points: 

 

·The proposal includes banning e-cigarette flavors other than tobacco and limiting the nicotine content in pouches to 0.99 milligrams per pouch. 

·EU reaction: Seven countries and the European Commission oppose the law, believing it violates the principle of free movement of goods. 

·Legal background: According to the EU principle of mutual recognition, a product legally sold in one member state should generally be allowed in other member states unless there are legitimate reasons. 

·Expert opinions: Patrik Strömer, Secretary General of the Swedish Snuff Manufacturers Association, criticized the lack of scientific basis for the law, calling it an ideological gesture. 

·Commission warning: Sandra Gallina, Director-General of DG SANTE at the European Commission, warned that some proposed restrictions are poorly designed and may backfire, harming public health. 

·Member states' positions: Countries like Italy and Greece strongly criticized the law, believing it is fundamentally inconsistent with the principle of free movement of goods in the European single market. 

·Spanish stance: Despite opposition, Spain is refusing to amend the law, leading to tension within the EU. 

·Future prospects: The matter now rests with the European Commission, which may demand Spain to modify the text or face the prospect of member states challenging Madrid in court.

 


 

According to a report from European Conservative on August 20th, the Spanish Health Ministry led by the far-left party Podemos has caused a stir in Brussels by proposing a draft law. The law would impose extensive restrictions on e-cigarette products and nicotine pouches, which several European Union member states believe violate the basic principle of free movement of goods.

 

The proposal includes banning e-cigarette flavors other than tobacco and imposing strict limits on nicotine content, setting the maximum nicotine content per pouch at 0.99 milligrams, effectively banning the use of nicotine pouches. Currently, nicotine pouches are in a regulatory grey area not clearly covered by the EU Tobacco Products Directive (TPD), giving member states broad discretion on the matter.

 

So far, the plan has been deadlocked due to strong opposition from seven countries including Hungary, Italy, Romania, Sweden, Greece, Czech Republic, Croatia, as well as the European Commission. According to the EU's principle of mutual recognition, a product legally sold in one member state should generally be allowed in other member states unless there are genuine reasons. Currently, 18 member states offer e-cigarettes in flavors other than tobacco, while nicotine pouches are sold in 13 member states.

 

This is a posture on ideology, not a serious public health policy," said Patrik Strömer, Secretary General of the Swedish Snuff Manufacturers Association. He believes that Spain's arguments lack scientific rigor and fail to meet EU proportionality standards. He stated that Spain's arguments rely on alarmist rhetoric and selectively chosen data, rather than the latest risk assessments. "They refer to tobacco as an 'epidemic,' which is a misleading analogy... tobacco use is not a contagious disease. And within the OECD, nicotine consumption is decreasing, not increasing.

 

Sandra Gallina, Director General of Health and Food Safety at the European Commission, has written to the Spanish Minister of Foreign Affairs warning that some proposed restriction measures are so poorly designed that they may actually have the opposite effect and harm public health. One example is Spain's plan to only ban unsafe e-cigarette ingredients that are already on the existing EU chemical list, which could allow other dangerous substances to slip through unregulated.

 

Italy has issued one of the strongest condemnations, stating that "the provisions in Spain's legislation are in serious inconsistency with the fundamental principle of free movement of goods in the European single market. This measure will introduce trade barriers within the internal market, which will have a negative impact on the key coordination goals set by European law.

 

Greece also echoed the criticism and urged for revisions, stating: "We demand that Spain modify the above provisions to ensure they not only align with the goals of public health protection, but also with the basic principles of free movement of goods and fair competition.

 

In Brussels, Spain is sticking to its guns and refusing to modify the law, despite these concerns, which has surprised many. Typically, member states adjust draft measures after receiving feedback from EU partners and the Commission. Stakeholders from countries like Romania are surprised by Madrid's inflexibility.

 

Currently, this matter has been handed over to the committee, which can request Spain to modify the text or face the prospect of member states challenging Madrid in court. With tensions escalating, this dispute highlights the delicate balance between national health policies and the core EU principle of market freedoms, potentially leading to a legal showdown for Spain in Luxembourg.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

China’s Jiangsu Tobacco Monopoly Bureau and Drug Regulator Target Illegal Vape Sales Disguised as Medical Devices, Define Six Violations
China’s Jiangsu Tobacco Monopoly Bureau and Drug Regulator Target Illegal Vape Sales Disguised as Medical Devices, Define Six Violations
China’s Jiangsu Tobacco Monopoly Bureau and Jiangsu Provincial Medical Products Administration have issued a joint notice targeting illegal production and sales of vape products disguised as medical devices. The notice identifies six categories of violations, including obtaining medical licenses through false materials, misusing medical device credentials, expanding production beyond approved scopes, and using medical device-related online platforms to promote or sell vape products. The action is based on China’s tobacco and medical device regulations and aims to strengthen vape oversight and consumer protection.
Aug.04
French Vape Market Under Pressure as Europe’s First Listed Vape Company Kumulus Vape Reports 7.8% H1 Revenue Decline, Retail Sales Rise 41.5%
French Vape Market Under Pressure as Europe’s First Listed Vape Company Kumulus Vape Reports 7.8% H1 Revenue Decline, Retail Sales Rise 41.5%
Kumulus Vape, Europe’s first publicly listed vape company, reported a 7.8% year-on-year decline in first-half 2026 revenue. Amid changing conditions in France’s vape market, the company said channel diversification helped offset pressure, with physical store sales increasing 41.5% year on year. Listed on Euronext Access Paris in 2019 and later transferred to Euronext Growth Paris, Kumulus Vape is viewed as a representative company of Europe’s vape sector. Its performance highlights the industry’s shift from rapid expansion toward more operationally focused growth.
Jul.27
FDA Authorizes Four More Nicotine Pouches as Review Pilot Expands Beyond Initial Decisions
FDA Authorizes Four More Nicotine Pouches as Review Pilot Expands Beyond Initial Decisions
The FDA has authorized four additional on! nicotine pouches, bringing the U.S. total to 30. The decision marks another outcome of the agency’s nicotine pouch review pilot, whose communication and review practices are now being applied more broadly across the category. It also extends Helix’s authorized portfolio from on! PLUS to the earlier on! line. Yet all FDA-authorized nicotine pouches still come from subsidiaries of PMI or Altria, underscoring how concentrated U.S. regulatory access remains.
Aug.05
Altria Smokeable Profit Rises 2.4% as Marlboro Share Falls and U.S. Discounts Gain
Altria Smokeable Profit Rises 2.4% as Marlboro Share Falls and U.S. Discounts Gain
Altria’s second-quarter results show a U.S. nicotine market splitting across price, product and regulation. Smokeable profit rose 2.4% as Marlboro pricing offset lower volumes, while discount brand Basic gained share among value-conscious smokers. In oral nicotine, on! PLUS expanded distribution but faced intensifying competition from ZYN and Velo. NJOY remained off the market as patent and regulatory hurdles delayed its return. The broader lesson: U.S. growth increasingly depends on price-tier strategy, retail execution, authorisation and enforcement readiness across the industry.
Special Report
Jul.31
Yinghe-Controlled Vape Maker SKE Ordered to Post £569,039 Security as It Pursues Crystal Bar Design Infringement Case in UK
Yinghe-Controlled Vape Maker SKE Ordered to Post £569,039 Security as It Pursues Crystal Bar Design Infringement Case in UK
The UK High Court has ordered Chinese vape manufacturer Shenzhen SKE Technology to provide £569,039 ($776,000) in security for costs in its design infringement proceedings against Vapepen London and other defendants over its Crystal Bar vape product. The court did not accept the defendants’ main argument that recovering costs from a China-based company would face significant enforcement obstacles, but found that SKE had not sufficiently disclosed its own financial position. The order is procedural and does not determine the underlying infringement claims.
News
Aug.21
FTC Scrutinizes Fifty Bar’s “Made in America” Claims as Vape Marketing Faces New Compliance Risk
FTC Scrutinizes Fifty Bar’s “Made in America” Claims as Vape Marketing Faces New Compliance Risk
The Federal Trade Commission sent a warning letter to Lucky Bar Holdings LLC over “Made in the USA” claims tied to Fifty Bar vape products, saying staff had reason to believe the products may be imported in whole or in significant part despite unqualified U.S.-origin marketing claims.
Jul.20